Author:
Keck Martin E.,Landgraf Rainer
Publisher
Springer Berlin Heidelberg
Reference99 articles.
1. Adams JB, Pyke RE, Costa J et al (1995) A double-blind, placebo-controlled study of a CCK-B antagonist, CI-988, inpatients with generalised anxiety disorders. J Clin Psychopharmacol 15: 428–434
2. Akiyoshi J, Moriyama T, Isogawa K et al (1996) CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder. J Neurochem 66: 1610–1615
3. Andari E, Duhamel J-R, Zalla T et al (2010) Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci 107: 4389–4394
4. Ault DT, Werling LL (1998) Neuropeptide Y-mediated enhancement of NMDAstimulated [3H] dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands. Brain Res 31: 27–36
5. Bakshi VP, Smith-Roe S, Newman SM et al (2002) Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J Neurosci 22: 2926–2935